PATENT CLAIM ANALYSIS

Application Number: 16241184
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "495000"]

Abstract:
The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.

Claim (Index 6):
The pharmaceutical composition according to  claim 1 , wherein the controlled release layer contains at least an excipient, such as co-binders, anti-sticking agents, antifoams, flavoring agents, pigments, processing aid agents, like plasticizers, emulsifier or stabilizer.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 99.0
- Lexical Diversity: 1.21739
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13129114', '13128950', '13148175', '12993704', '12678406']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7595752652489122
- 35 USC 102 Novelty (BERT): 0.5861133758579951
- Combined Prediction Score: 0.7422290763098205
- Mean Citation Score: 329.5836920000001
- Max Citation Score: 543.97235
- Similarity Product: 398.73123556598426

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test